I spoke with Rebecca Wilson today and asked about ATH434 and PBT2.
After speaking with Rebecca, i felt she was somewhat limited with what she could say. Having said that……
With regards to ATH434, an update will be included in the quarterly reports to released later this week.
With regards to PBT2, Alterity’s focus is on ATH434, and that the University of Queensland (UoQ) is working hard on researching antimicrobial resistance. If and when UoQ presents research data of significance to Alterity, then and only then will Alterity take appropriate action.
I spoke with Rebecca Wilson today and asked about ATH434 and...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $4.263K | 916.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 69165915 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38212524 | 21 |
View Market Depth
| Last trade - 15.11pm 05/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |